foxo4 dri senolytic 2024 FOXO4-DRI 10mg vial - Description The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications A) FOXO4 and p53 regulate cellular senescence by recognising the Download Scientific Diagram FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry
Pay in 4 interest-free payments of $5.70 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23



